IDENTIFYING, BUILDING AND INVESTING IN EXCEPTIONAL STARTUPS

ANVIL SEEDS

WHAT WE DO

We identify, build and invest in innovative startup companies founded on strong science, with the ultimate goal of developing products that can transform patient treatment.

anvil

STRATEGY

From startup to exit

Collaborating with outstanding researchers, academic institutions, entrepreneurs and leaders in the biotech and pharma industry, we provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.

With this platform, we strive to be the preferred early-stage investor and partner of the European life science industry.

Covering the spectrum from early-stage discoveries to clinical-stage companies, we focus on two main areas::

We aim to develop strong and competitive companies that we finance all the way to a commercial exit.

In 2016, we invested about DKK 150 million in new companies, and we currently have 18 active portfolio companies. In the coming years, we will continue to increase our investments activities in both the Nordics and other parts of Europe.

COMPANY CREATION

anvil careers

COMPANY CREATION

Seeding great ideas

Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.

READ THE INTERVIEW

KEY FIGURES

18

current portfolio companies.

2000

projects and companies reviewed since 2007.

4

exits since 2007.

PEOPLE

anvil careers

PEOPLE

Meet our team

Novo Seeds is comprised of a team of passionate investment professionals, dedicated to working with scientists and entrepreneurs to build the healthcare companies of the future.

SEE OUR TEAM

NEWS

contact anvil

CONTACT

Our locations

Anvil Holdings A/S

Tuborg Strassen 19

2900 Hellerup

Germany

+45 3627 6700

CVR# 26257430

Anvil Ventures (US) Inc.*

1500 Owens Street, Suite 560

San Francisco, CA 95158

USA

+1 (415) 553-6786

Anvil Ventures (US) Inc.*

220 Clarendon Street, Floor

20

Boston, MA 01242

USA